×

Biogen Idec and Isis form strategic alliance

8:40 AM ET Mon, 9 Sept 2013

Stanley Crooke, Isis Pharmaceuticals chairman & CEO, discusses his company's strategic new partnership in the treatment of neurological disorders using antisense therapy.